Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Purdue Pharma Dr Alan DuntonPurdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its executive committee.

Dr Dunton will serve as the company's lead scientist and oversee medical research, drug safety, clinical pharmacology, virtual discovery, project management, and pharmaceutics and analytics teams.

He will report to chief executive officer Mark Timney who said: "At a time of transformation for Purdue, Alan brings the right skills and

experience to diversify and grow our portfolio."

Dr Dunton has spent 33 years in the industry discovering and developing new prescription and over-the-counter products. In 2006, he

founded Danerius, a biotechnology and pharmaceutical consulting business, which he led until joining Purdue. 

Prior to starting Danerius, Dr. Dunton held executive-level positions in the pharmaceutical and biotechnology industries, including President and Chief Executive Officer of Panacos Pharmaceuticals and Metaphore Pharmaceuticals.

He was also the president and managing director of the Janssen Research Foundation, the R&D arm of the pharmaceuticals division at Johnson & Johnson.

7th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics